Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My impression from his email is the filings will do that.
All we can do is wait I guess.
GMOS - If anybody is still interested I received an email from J. Denunzio
Filings and updates are imminent.
You may want to position yourself prior to updates hitting.
Good luck.
If anybody is still interested I received an email from J. Denunzio
Filings and updates are imminent.
You may want to position yourself prior to updates hitting.
Good luck.
GMOS .10 OTCMarkets updated the officer and director information yesterday.
I see another shell - AXMP - had trading suspended.
Not sure why all you shell traders seem to be avoiding/ignoring GMOS. GMOS has the lowest share structure of all these shells on here by a mile. OS is 12.9 million and float is under 4 million.
I see LRDR went down on the AXMP news. With LRDR trading at .015 the market cap is still at $43.5 million.
GMOS market cap is $1.3 million. For GMOS to be equal to LRDR market cap GMOS would have to trade at $3.35
And as a bonus the share structure of GMOS is smaller than NUGS. You know, the shell that went to $7.00+ on merger news and developments.
HELLOOOOOOOOOOOOO
Up until yesterday OTCMarkets did not have Paul Moody listed. They had the old owners listed. The Haugens (or something like that) were listed.
OTCMarkets updated that information yesterday.
OTCMarkets just updated Company Officers and Directors. Getting closer.
GMOS is even valued at 1/2 of VUME who just had their deal fall through. Funny stuff.
Why very little interest here compared to UCRP, LRDR, AXMP etc?
Of all the shells GMOS appears to be the best situated for the biggest returns. Yet it's mostly ignored.
I've been watching OTCX undercut the ask. Strange stuff.
Does the amended designation of series A preferred shares indicate the merger in company will be announced soon?
And is this series A preferred filing a good thing?
It's so very thin too. It just has that look of one that could move to multiple dollars.
I'm sitting on my shares. Can't buy more or I'd gamble here at .10 on more shares.
GMOS - FYI Denunzio wedding was on June 15th or 18th (forgot which one) but then the obvious honeymoon. Knowing the rich family type it was probably 2+ weeks.
So maybe some updated filings soon after the 2+ week delay.
Also, GMOS still is undervalued compared to all shells in play. Even the sister UCRP shell.
All things being equal GMOS is the better value by far. It's common sense based on share structure and market cap. Just using UCRP at .026 x .035 as an example GMOS should be .13 x .17 to offer similar value.
Very odd.
FYI Denunzio wedding was on June 15th or 18th (forgot which one) but then the obvious honeymoon. Knowing the rich family type it was probably 2+ weeks.
So maybe some updated filings soon after the 2+ week delay.
Also, GMOS still is undervalued compared to all shells in play. Even the sister UCRP shell.
All things being equal GMOS is the better value by far. It's common sense based on share structure and market cap. Just using UCRP at .026 x .035 as an example GMOS should be .13 x .17 to offer similar value.
Very odd.
profund the market cap is $1 million. Still fractions of all these other shells. GMOS is the best chance for a huge run even though all the big cheese Ihubbers are pushing the others. Mindboggling actually.
I lucked out on the timing initiating a position. I hope to add when possible.
GMOS .08 market cap is now $1 million. This compares to UCRP .031 market cap of $2 million.
Can anybody give a reason why UCRP should be valued 2 times that of GMOS?
I'm all ears.
GMOS remains the best shell play of all these Arcaro/Bauman/Denunzio shells.
GMOS .08 market cap is now $1 million. This compares to UCRP .031 market cap of $2 million.
Can anybody give a reason why UCRP should be valued 2 times that of GMOS?
I'm all ears.
GMOS remains the best shell play of all these Arcaro/Bauman/Denunzio shells.
CUIN2 - That question wasn't meant to be a shot at longs although it did sound like it. What I was trying to ask/imply is if it's a great technology why not just buy more shares as it goes down and grin like the Cheshire cat.
Before buying any more
1) Why did the CEO suddenly go quiet?
a) Something positive like merger, acquisition or buyouot?
b) Something negative like SEC investigation into SHAC videos, etc
2) Where are all the PR's he mentioned in his SHAC videos? There were so many deals it was hard to keep track. Yet none have been announced.
3) Is the lawsuit really BS? Will it get dismissed? Or does FUSZ want it to go to trial to possibly get money/shares back from EMA?
4) Is the technology really that amazing? I admit, I don't know. It looks cool but don't know if it'll generate $20,000 or $20,000,000 per month in revenues when it's adopted.
5) Is anybody still receiving emails from CEO?
Agree here too. GMOS much better value than UCRP. But gotta play what's hot at the time too.
GMOS getting a little bit of buying action past couple of days. Maybe next week the filings get updated. Then it'll get interesting with the little OS and float.
Just once it would be interesting to see most of the big Ihub players with large followings all get into a stock. And what better one than GMOS with it's share structure. It would be amazing I think.
Agree. But it could go up much higher if the group that was in UCRP was in GMOS instead.
For example if it goes to a $3 value and stays there when merger in company is announced there's nothing wrong with that. But if the IHub players were in with huge positions GMOS could run to $6+ before settling back to $3 fair value
But either way it'll do what it's going to do.
GMOS still not getting the attention that other shell companies are. It's really bewildering.
The market cap of GMOS is fractions of the other shell companies. All things being equal GMOS is THE buy of the shell companies.
UCRP and GMOS are exactly the same situation. Everybody (and me too) bought into UCRP. I noticed the chatter on UCRP was more than the chatter on GMOS so I bought some. And the share price was near a penny while GMOS was 10 cents. So we could buy 10 times more shares in UCRP than GMOS.
It's paid off already.
But still the best chance from here to make a serious run is GMOS. The market cap is still under half of UCRP. It's a no brainer which one to buy yet traders are still concentrating on UCRP.
I still think GMOS will get the best merge in company Denunzio/Moody are considering. GMOS at .14 is a much better buy than UCRP at .04
If I knew the Ihub groups will play GMOS like UCRP I'd buy as much GMOS as possible.
GMOS still not getting the attention that other shell companies are. It's really bewildering.
The market cap of GMOS is fractions of the other shell companies. All things being equal GMOS is THE buy of the shell companies.
UCRP and GMOS are exactly the same situation. Everybody (and me too) bought into UCRP. I noticed the chatter on UCRP was more than the chatter on GMOS so I bought some. And the share price was near a penny while GMOS was 10 cents. So we could buy 10 times more shares in UCRP than GMOS.
It's paid off already.
But still the best chance from here to make a serious run is GMOS. The market cap is still under half of UCRP. It's a no brainer which one to buy yet traders are still concentrating on UCRP.
I still think GMOS will get the best merge in company Denunzio/Moody are considering. GMOS at .14 is a much better buy than UCRP at .04
If I knew the Ihub groups will play GMOS like UCRP I'd buy as much GMOS as possible.
GMOS .13 some small buys today pushed it up a tad.
The float sure is small.
It's a good thing that some big cheeses on IHUB have bought into GMOS. I'm sure my small position is a pittance compared to their positions. What I've learned in my short stay on the 'hub is that the big cheeses can move stocks. I'd love to see several big cheeses work together on GMOS. It would be spectacular to see.
CYPE bounced back the past couple of days. That bodes well for the whole shell sector. ha.
I would love to see a big company merge into the GMOS shell. With the share structure as small as it is the moves up could be violent.
Lets get some cheese.
3 million shares trade with the majority buys would send this over $1.00 easily. Maybe much higher.
It is amazing that the one with the best chance for HUGE gains is for the most part ignored compared to others.
I just looked at AXMP and their market cap is over $40 million.
GMOS would need to be over $3.00 to have a comparable market cap.
Correct me if I'm wrong but the next step in this process is the OTCMarket filings and updated information. And then the merge in company announcement?
I also went back and looked at the NUGS share structure while going through the custodianship and RM process.
GMOS share structure is actually even smaller than NUGS. I didn't realize this until this morning.
If a solid company merges in GMOS could go on an epic run.
I'd love to buy more if one of my other stocks would pop up some. But no luck so far on those others.
It is amazing that the one with the best chance for HUGE gains is for the most part ignored compared to others.
I just looked at AXMP and their market cap is over $40 million.
GMOS would need to be over $3.00 to have a comparable market cap.
Correct me if I'm wrong but the next step in this process is the OTCMarket filings and updated information. And then the merge in company announcement?
I also went back and looked at the NUGS share structure while going through the custodianship and RM process.
GMOS share structure is actually even smaller than NUGS. I didn't realize this until this morning.
If a solid company merges in GMOS could go on an epic run.
I'd love to buy more if one of my other stocks would pop up some. But no luck so far on those others.
LRDR and GMOS wow.
For basically the same situation (shells) LRDR is valued over $100 million while GMOS is about $1 million.
Absolute incredible and ridiculous difference.
To equal LRDR market cap GMOS would need to be trading at $8+
Astounding.
I know I'm new. And I defer to those more experienced but I rewatched some SHAC and other videos and don't think the "big news" is an uplisting. CEO Cutaia mentioned during the LD Micro presentation that FUSZ would need a couple quarters of results before entertaining an uplisting.
My guess is a merger or acquisition. Or a very large deal with a giant.
However, if whatever it turns out to be is really huge then an uplisting could be expedited.
I like the risk/reward here. I'll keep adding the next 2-3 weeks when I can.
If anybody has any information to share that they don't want put on here feel free to private message me. The more info the better.
I got a starter position last week.
At one of the conferences a participant asked something along the lines of does NFusz share data to 3rd parties. And CEO Cutaia answered something like if the largest market cap company out there wants to share 3rd party information after buying us out then it's up to them (or something like that)
And I believe Apple is the largest market cap company in the world.
Is an Apple buyout possible?
GMOS - yes bullion, GMOS is the most undervalued of the shell companies in play. It's not even close.
GMOS only has 12.9 million shares outstanding. The float has been rumored to be about 4 million. I have a suspicion the float is locked up by a few larger players. Probably why the stock hardly trades and the reason any buying starts the price moves violently upward.
GMOS is similar to UCRP. They both have the same players involved (custodian, attorney, etc). However, GMOS is over a month ahead in the timeline for a company to merge in. And GMOS is less than half the market cap of UCRP.
If Denunzio doesn't do all he can to make GMOS work for shareholders then I believe UCRP will crash and these shells die out. Just my opinion. That is why I think he will put his best company he can into GMOS.
I still think GMOS is the best chance to make a NUGS-like run. The smaller the OS the more chance a big run can occur. It's basic common sense. And if GMOS merges in a legitimate, big company it'll be an amazing thing to watch as all the IHubbers jump on the train.
Also if the big IHUB shell players and those with large followings start chatting constantly about GMOS it'll add to the fire. Why they haven't and are focusing on the other is odd.
I got very lucky with CYPE and can afford to just ride GMOS and UCRP out. If GMOS doesn't work out I'll sell them both off and walk away with a huge profit and not think twice about it.
GMOS - yes bullion, GMOS is the most undervalued of the shell companies in play. It's not even close.
GMOS only has 12.9 million shares outstanding. The float has been rumored to be about 4 million. I have a suspicion the float is locked up by a few larger players. Probably why the stock hardly trades and the reason any buying starts the price moves violently upward.
GMOS is similar to UCRP. They both have the same players involved (custodian, attorney, etc). However, GMOS is over a month ahead in the timeline for a company to merge in. And GMOS is less than half the market cap of UCRP.
If Denunzio doesn't do all he can to make GMOS work for shareholders then I believe UCRP will crash and these shells die out. Just my opinion. That is why I think he will put his best company he can into GMOS.
I still think GMOS is the best chance to make a NUGS-like run. The smaller the OS the more chance a big run can occur. It's basic common sense. And if GMOS merges in a legitimate, big company it'll be an amazing thing to watch as all the IHubbers jump on the train.
Also if the big IHUB shell players and those with large followings start chatting constantly about GMOS it'll add to the fire. Why they haven't and are focusing on the other is odd.
I got very lucky with CYPE and can afford to just ride GMOS and UCRP out. If GMOS doesn't work out I'll sell them both off and walk away with a huge profit and not think twice about it.
I'm not bashing VUME but if all things are equal GMOS will outperform VUME by 4 times just due to the market cap variance.
But obviously it all depends on the merge in companies
This is a very interesting looking company. I'm no software expert but if the product is being integrated into all the big CRMs then there is a chance of this catching fire in the next several months. Keep the OS reasonable and this could make shareholders a mountain of cash in the medium term future.
If anybody has any insights to share feel free to PM me. I can understand from reading this board if you want to keep things private.
Where can I see this Apple buyout rumor/statement?
Wowza. All these Bauman/Arcaro/Denunzio/Moddy shell companies and it's not even close. The lowest market cap by far is GMOS.
Comparing GMOS to the similar UCRP is eye opening. GMOS would have to triple to about .33 to match the market cap of UCRP. And both of them pale in comparison to the Arcaro market caps of 10's of millions.
I still say GMOS is the best opportunity for a NUGS like runner.
I had to pick up a small UCRP position. For some odd reason that seems to be more in favor than GMOS.
UCRP market cap is $4.2 million
GMOS market cap is $1.5 million. And GMOS is a few weeks ahead in the RM process than UCRP.
If the disconnect between GMOS and UCRP remains when the June 13 UCRP custodianship is granted just out of common sense I'll have to sell the UCRP and pick up the out of favor GMOS.
Wowza. All these Bauman/Arcaro/Denunzio/Moddy shell companies and it's not even close. The lowest market cap by far is GMOS.
Comparing GMOS to the similar UCRP is eye opening. GMOS would have to triple to about .33 to match the market cap of UCRP. And both of them pale in comparison to the Arcaro market caps of 10's of millions.
I still say GMOS is the best opportunity for a NUGS like runner.
I had to pick up a small UCRP position. For some odd reason that seems to be more in favor than GMOS.
UCRP market cap is $4.2 million
GMOS market cap is $1.5 million. And GMOS is a few weeks ahead in the RM process than UCRP.
If the disconnect between GMOS and UCRP remains when the June 13 UCRP custodianship is granted just out of common sense I'll have to sell the UCRP and pick up the out of favor GMOS.
SMH
GMOS market cap $1.3 million
UCRP market cap $3.3 million
LRDR market cap over $50 million
and the list goes on.
My first shell. And what a pick it was
Amazing events
CYP@ is working out beautifully. On other social media sites I was steered to LRD# instead of CYP# but I chose CYP# for the same reasons I am choosing GMOS instead of UCR+ (although I have no problem with buying UCR^ due to it's tiny market cap compared to the Arcaro shells).
THE GMOS SHARE STRUCTURE IS THE BEST BY FAR OF THE SHELLS I SEE ARE IN PLAY.
Anyways, back to GMOS. Did a bit of digging. PEM LLC is owned by Patrick E Meyers. Meyers was hired as Chief of Staff late last year for the governor of Colorado.
He was heavily involved in Consumer Capital Partners for 16+ years with his college "buddy" who is the CEO. One of CCP's companies Smashburger grew to a $338 million revenue company in 2016. The big push now for CCP is Toms Urban. It looks like an awesome restaurant in fantastic locations. And they are looking to expand.
Just mentioning it as a possible merge in company. I have no further information as of now. Of course ANY company is a possible candidate but just throwing that out here for now as a connection. I'm speculating CEO of CCP may want to go public route with Toms Urban but it's just a hunch. Nothing more.
If I find anything of interest I will share. But that's all I have so far. Meyers can be found on LinkedIn and Bloomberg if you'd like to read his bio. It's good.
I thought of that too. But since the same attorney is being used I'm speculating GMOS will be a quick one also.
More than likely at the wedding Denunzio will be touting his RM shells to the gathering. Heading to the men's room a guest of the bride runs into Denunzio, "Hey, what's a good stock to buy?". Denunzio "GMOS, it's a shell company we're grooming for a huge merger". He will not want to let down his new relatives lol. Maybe it's far-fetched but maybe not.
The smaller OS (vs UCRP) offers the best chance for a huge run and payday. That's just the way I see it. If GMOS shareholders take a screwing in any way then UCRP is doomed. I don't see Denunzio messing it up.
I'm still astounded at the market caps of the Arcaro shells. GMOS could go to $2.00 and still look "undervalued" compared to the Arcaro shells. It's all the same process. It's just a matter of what company is put in. If it's a big company (and I think it could be for the reasons mentioned) GMOS could be NUGS 2.0 down the line.
I'm new to shell companies. I've been following a few to learn how they work. My one pink sheet stock that I thought was going to make me lots of money has pretty much been stuck for a couple years near a penny. That is why I started digging for different avenues to make money.
I watched and am watching the Arcaro plays. There's been some extraordinary valuations and runs. So I bought some CYPE. I was late to the party but it's working out well as we wait for the merger in company.
So with the rest of my small cash position I wanted to buy another shell. Hopefully find one before the custodian hearing. I looked into GMOS and UCRP. Both with very low market caps. I decided on GMOS for several reasons that I think make sense:
1) Low OS of just under 13 million. And I'm assuming the float is much smaller than any of the shells I've looked at.
2) Bauman attorney. He's the same attorney that Arcaro uses.
3) Hearing is 5/24 vs UCRP hearing in early June.
Most of the Arcaro shells have had market caps that have exceeded $25 million. Some $50 million. And some $100's of millions. The market cap of GMOS is a bit over $2 million. Compared to Arcaro's shells this is undervalued 10-fold. A run to 50 cents is still only a $6 million market cap.
Obviously Denunzio and Arcaro are 2 different people. But the "shell game" is the same.
I think if Denunzio doesn't come through for shareholders with GMOS then UCRP will sell off and all future Denunzi shells will be avoided. Add the fact that he's getting married soon and this may be Denunzio's shot at NUGS 2.0.
I think he will put the best company possible in GMOS and set the table for the rest of his future shell acquisitions.
Add that it's possible that some of the heavy hitter posters/groups get interested and GMOS could very well be over $1.00 throughout the process. It's been a quiet board thus far.
I did a little DD over the weekend trying to get a better understanding of what's happening. I hope you enjoy.
RJD Green DD
Facts
AS 750 million. OS 209 million + possible 20 million from Oct 6 2017 filing. No preferred shares OS. No convertible debt.
FYE August 2016 revenues $3.8 million. Net Income $797,000. EPS (using current 229M OS) = .00348
First 9 months of FYE August 2017. Revenue $2.6 million. Net Income $322,000. 9 month EPS = .0014
(note - these 9 month results were much better than 2016 9 month results. Obviously 4Q 2016 was a very good Q)
MY THOUGHTS. There are 2 important things that need to be done to move market cap up substantially. Audit completion and Iosoft traction. If RJDG shows evidence that they are on their way to their projected $9.6 million Iosoft revenues for 2018 (along with increasing the roughly $4.0 million existing revenues from other divisions) and they get these numbers audited then I believe RJDG market cap should be at least $25 million. This number is based on the 70% EBITDA for Iosoft and past net income for Silex division along with a modest PE of 10-15 and/or price to sales of 1-2. A $25 million market cap would push the share price over .10 (229M estimated OS) But as you will see from Iosoft projections future revenue could be multiples of 2018 revenues.
1) Audit History
March 28, 2017 press release. RJD Green Inc. announced the engagement of audit firm Zwick & Banyai, PLLC.
We expect to initiate audits within four weeks.
April 25, 2017 press release. RJD Green, Inc. announced the approved engagement by audit firm Zwick & Banyai, PLLC, and the firm has set a date of May 22, 2017 to initiate audits. The firm expects to conclude the audits within a four to six week period post initiating the audit.RJD Green upon completion of audits will file to move to OTC.QB fully reporting status.
August 8 2017 press release "RJD Green previously announced our expectation to commence auditing, in late May, auditing for uplift to OTC.QB fully reporting status. Upon reflection our Board of Directors requested auditing 2016 and 2017 since our fiscal year ends August 31, which was only three months away. The reason for the Board's decision was the cost savings created by waiting three months until the 2017 fiscal year ends, eliminating an additional year's audit expense.
Having completed our reporting through the third quarter of 2017; our team has geared for completion of the year-end information by mid-September for audit. Upon completion of the audits RJDG will immediately file for uplift to OTC.QB fully reporting status.
MY THOUGHTS. As a shareholder for about a year with an average price about .015 I'm not happy with the audit delays. I think it's important to get the numbers audited. But it actually made sense to audit FYE August 2016 and FYE August 2017 instead of 2015, 2016 and 2017. Obviously it would cost more to audit 3 years instead of just 2. And as you can see from above RJDG press release they mentioned the reason to wait was for "cost savings created by waiting three months until the 2017 fiscal year ends, eliminating an additional year's audit expense." I'm speculating the reason for the split with Zwick & Banyai was due to lack of ability to pay for 3 year audit. The May 2017 balance sheet showed $84,000 cash.
As a result of this you can see from October 6 2017 filing they sold some vendor debt for shares. Mr. Rabbit states; “This transaction allows RJD Green to utilize the monthly cash flow previously allocated to the retired debt, to provide the required capital for non-reoccurring expenses that include; the two year audit for uplifting, the uplifting to OTC.QB, and due diligence and escrow expense of the next planned RJD Green acquisition. They now have the cash to pay the auditor to complete the audit.
I have reached out to CEO Ron Brewer and confirmed there is a new auditor that will do the audit.
2) Iosoft Sales
April 2016 RJDG bought Iosoft. Mr. Brewer states; “IOSOFT’s existing three-year mean annual EBITDA is $182,297. The enlarged sales opportunity is projected to create a mean three-year revenue over $50,000,000 with 70% EBITDA.
June 6 2016 CEO, Ron Brewer, announced today the IOSOFT Division of RJD Green Inc. has reached an agreement to provide services and technology platforms for a premier provider of technology services to the healthcare industry nationally.
Contracts are scheduled to be executed in June, and services launched in July of this year.
After months of research and development, IOSOFT was chosen to provide "best in class" payment technology to more than fifty TPAs, Health Plans and insurance payers.
September 13 2016 announced that IOSOFT, Inc. a division of RJD Green Inc., has been retained by a multinational travel and hospitality payments company, to provide "best in class" payment technology for United States operations.
The Companies have executed non-disclosure agreements and will begin trading technical specifications and trade secret information. Although not in the healthcare payments industry, this multinational corporation hopes to gain a foothold in the $4 trillion travel and hospitality market. It has chosen IOSOFT for its experience and deep institutional knowledge and its well-known technical expertise in virtual payment processing.
February 22 2017 RJD Green CEO, Ron Brewer, announced today the IOSOFT Division of RJD Green Inc. has reached agreement to provide services and technology platforms to PlutoXPay, a new venture of A & G Healthcare, a premier provider of cost containment services to healthcare providers nationally.
Sales & revenues are expected to be initiated in the next month. Revenue performance, based on historical industry standards, could be greater than $30,000,000 annually.
After extensive development, IOSOFT was chosen to provide "best in class" payment technology to more than ninety TPAs, Health Plans and insurance payers.
May 2 2017 RJD Green Inc. announced the IOSOFT Inc. sales launch, and rollout of their next generation payment software has been met with a huge response in the healthcare payment space.
From presentations at healthcare expos, where IOSOFT's offering generates real enthusiasm among attendees, and initial marketing efforts of its nine salespersons to strategic payer companies (TPA); commitments from healthcare administrators has been greater than planned or expected.
IOSOFT is in beta processing with three payer firms, and with three companies moving to the full implementation of the software services over the next sixty days. IOSOFT has further commitments to initiate the beta process.
As customers move to full launch of services over the next sixty days, IOSOFT management expects monthly revenues to ramp over $100,000 with profits over $76,000.
As the Company meets this benchmark, rapid acceleration of revenues to previously budgeted projections is expected on a monthly basis.
June 20 2017 RJD Green Inc. announced the beta implementation process has been completed and initial implementation revenues will be completed in July with full revenue streams coming forward in August. Annual revenues for their first contract are expected to exceed $240,000 annually.
IOSOFT begins beta processing with four additional contracted clients, two beginning in August and two in September with full implementation of the software services over the sixty days beta processing launch. IOSOFT has additional contracts forthcoming on a monthly basis, which will accelerate in quantity per month launched after the current four companies are fully implemented.
As these initial clients are fully implemented, revenues are projected to be over $1,100,000 annually from the initial five
clients.
As IOSOFT completes this benchmark, rapid acceleration of revenues to 2018 budgeted projections is expected on a continuing monthly basis.
September 26 2017 RJD Green Inc.'s Healthcare Services Division announced it has procured an initial eight contracts to implement in the fourth quarter of calendar year 2017 and first quarter of calendar year 2018. The final implementations of three contracts are under way. A twelve month revenue expectation from these initial contracts is $9,600,000.
Vincent Valentine, IOSOFT President, states:
"After unforeseen delays we are excited to start creating the revenues we expected six months ago. Our marketing partners are now very active in the health service community nationally and they fully expect to continue growing our revenues monthly, which allows us to meet the significant revenues forecast for 2018.
"From ongoing negotiations that are occurring now, we expect to see more accelerated monthly contracts procured in the first calendar quarter of 2018."
MY THOUGHTS. Very confusing with so many balls in the air for Iosoft. But I think the key is the May 2 2017 press release about the launch of their new product. Their 9 salesmen generated better than expected interest from TPA's (Third Party Administrators). The juggling of beta tests, full implementations along with new beta tests and implementations makes it difficult to follow and understand when and how much revenue will occur. But what is apparent is that Iosoft is picking up steam and it looks like all systems go.
I learned Iosoft launched the actual payment and billing software in November. My guess is this is why things were pushed back. But now things are beginning to pick up and the reason why they reiterated the $9.6 million revenue forecast for 2018.
Overall I think RJDG suffers from a lack of awareness. Couple that with most of the trader's focus this past year on marijuana and bitcoin stocks and you can see why there's lack of interest. The delays in audit and Iosoft sales certainly add to that. But if you go read the press releases and OTCMarket filings you can see the story developing. I'm not sure anybody has "put the pieces together". But the posted numbers for 2016 and first 9 months 2017 (remember FYE August 2017) are solid and just based on those it deserves a much higher market cap. And if I'm right about the audit and Iosoft then RJDG is a steal here going into what could be an explosive 2018.
It's also possible the timing of events over the next 6 months could work to shareholder's advantage. FY 2017 ended August 31, 2017. 10K should be out by December 15, 2017 (NTK filed) along with updates on Iosoft sales and audit progress. And Q1 2018 ended November 31, 2017 so the 10Q should be out by January 15, 2018. Q2 2018 ends February 28, 2018 and should be filed by April 15, 2018. I'm guessing around this time the audit should finally be done and Iosoft revenues should be significant. An audited RJDG with increasing Iosoft sales uplisting to QB tier would be a stock I want to own.
And just to stress how undervalued RJDG is currently. Suppose Iosoft "only" does $2 million for 2018. The revenue would be over $6 million with net income a little over $2 million. So a horrible year would get you an EPS of a penny. And you'd be sitting on shares you bought at a penny. Now that's what I call risk/reward in shareholder's favor.
My first post on Investorshub. I'm not new to trading though. Have been fortunate enough to be able to do this for a living the past 12 years. I like to find low cap stocks that can become bigger cap stocks. I believe this is a great candidate to appreciate hundreds of percents from under a penny. My friend does great investigating of stocks and he shares what he finds with me. I don't buy every stock he mentions but did buy this.
I have a sizeable position in RJDG. The numbers are just too good for this to be ignored too much longer. 2018 is shaping up to be a very profitable year for this company. The Iosoft division looks as if it will start to do the heavy lifting going forward.
Now to go see if my other stocks are on here too. haha
And if anybody has any tips feel free to send me a message.